Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vonoprazan 10 mg vs 20 mg for PPI-refractory functional dyspepsia (pilot)
TCTR20230504003Phase 3Unknown
- Sponsor
- Rajavithi Hospital
- Start
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of vonoprazan in functional dyspepsia (FD), sponsored by Rajavithi Hospital. Status: unknown.
02
Drugs
vonoprazan
03
Conditions
functional dyspepsia (FD)
Beyond the preview
Go deeper on TCTR20230504003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20230504003.